These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3045371)

  • 41. Human bone marrow stromal cell lines from myeloma and rheumatoid arthritis that can support murine pre-B cell growth.
    Kaisho T; Oritani K; Ishikawa J; Tanabe M; Muraoka O; Ochi T; Hirano T
    J Immunol; 1992 Dec; 149(12):4088-95. PubMed ID: 1281201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin B(6) supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis.
    Huang SC; Wei JC; Wu DJ; Huang YC
    Eur J Clin Nutr; 2010 Sep; 64(9):1007-13. PubMed ID: 20571496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiotype-bearing and antigen-binding receptors produced by blood T lymphocytes in a case of human myeloma.
    Preud'homme JL; Klein M; Labaume S; Seligmann M
    Eur J Immunol; 1977 Dec; 7(12):840-6. PubMed ID: 75800
    [No Abstract]   [Full Text] [Related]  

  • 44. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
    Williams RO
    Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [T and B lymphocyte subpopulations with HLA-DR surface molecules in rheumatoid arthritis, using a monoclonal lymphocytotoxic antibody. Poorly and highly developed rheumatoid arthritis].
    Mercier P; Dallest R; Olmeta C; Gaborit P; Gatti P; Roux H
    Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):713-9. PubMed ID: 6975966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Involvement of lymphocyte populations in rheumatoid synovial lesions].
    Clot J; Charmasson E; Rosenberg F; Sany J; Serre A
    Ann Immunol (Paris); 1977; 128(1-2):297-9. PubMed ID: 322585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.
    Depper JM; Bluestein HG; Zvaifler NJ
    J Immunol; 1981 Nov; 127(5):1899-902. PubMed ID: 6271870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitogens of B and T cells from peripheral blood in rheumatoid arthritis.
    Clot J; Mathieu O; Sany J; Serre H
    Rheumatology; 1975; 6():199-208. PubMed ID: 1081725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of eicosanoids and cytokines in immune regulation.
    Lewis RA
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():170-8. PubMed ID: 1698010
    [No Abstract]   [Full Text] [Related]  

  • 50. [B-lymphocyte hyperreactivity and differentiation factors of T-lymphocytes in systemic lupus erythematosus].
    Humbert M; Galanaud P
    Ann Med Interne (Paris); 1990; 141(3):213-6. PubMed ID: 2369009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study of cellular immunity in rheumatoid arthritis].
    Suteanu S; Moanga M; Stefanesco DT; Bancou A; Dragomir CT; Pirvu-Blaja V; Rindasu G
    Rev Rhum Mal Osteoartic; 1978 Jun; 45(6):395-9. PubMed ID: 308252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of suppressor T cell function in patients with rheumatoid arthritis: defects in production of and responsiveness to concanavalin A-induced suppressor T cells.
    Sakane T; Takada S; Murakawa Y; Kotani H; Honda M; Ueda Y
    J Immunol; 1982 Nov; 129(5):1972-7. PubMed ID: 6214584
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immunologic and ultrastructural analysis of lymphocytes in rheumatoid synovial fluid].
    Gabrielescu E; Stoicescu M; Codorean E; Niculescu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(6):567-74. PubMed ID: 2871616
    [No Abstract]   [Full Text] [Related]  

  • 54. Circulating B and T lymphocytes in myeloma and benign monoclonal gammopathies.
    Büchi G; Termine G; Girotto M; Gario S; Autino R
    Haematologica; 1983; 68(2):179-89. PubMed ID: 6407913
    [No Abstract]   [Full Text] [Related]  

  • 55. Interleukin 21 as a target of intervention in autoimmune disease.
    Ettinger R; Kuchen S; Lipsky PE
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii83-6. PubMed ID: 19022821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New therapeutic possibilities. Future aspects].
    Rubbert A; Burmester GR
    Internist (Berl); 1993 Sep; 34(9):841-51. PubMed ID: 8407201
    [No Abstract]   [Full Text] [Related]  

  • 57. Markers of activated T cells on synovial fluid lymphocytes in rheumatoid arthritis.
    Mathieu A
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):774-8. PubMed ID: 317895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cellular defense mechanisms in rheumatoid arthritis and juvenile rheumatoid arthritis].
    Puławska J
    Wiad Lek; 1984 Feb; 37(4):273-80. PubMed ID: 6235675
    [No Abstract]   [Full Text] [Related]  

  • 59. HLA-DR positive T lymphocytes in blood and synovial fluid in rheumatoid arthritis.
    Kluin-Nelemans HC; van der Linden JA; Gmelig Meyling FH; Schuurman HJ
    J Rheumatol; 1984 Jun; 11(3):272-6. PubMed ID: 6610750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Behavior of thymus-dependent and bursa-dependent lymphocytes (T and B) in some lymphoproliferative diseases].
    Barabino A; Di Benedetto G; Franceschini R; Indiveri F; Puppo F; Soldà AM
    Boll Soc Ital Biol Sper; 1975 Nov; 51(22):1612-6. PubMed ID: 1084753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.